Alison Birtle

Consultant Clinical Oncologist Alison BirtleJob Title: Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer

Department: Cancer (oncology)

Telephone Number: 01772 524762

Primary Medical Qualifications: MB BS MRCP FRCR MD

Other Qualifications: BSc

Year of Registration: 1992

GMC Number: 2674862

Career History: General medical and specialist registrar oncology training undertaken in London Charing Cross and Westminster. MD Thesis completed at the Institute of Urology, University College London, and Academic Urology Unit, Royal Marsden Hospital. Currently working as a Consultant Clinical Oncologist for Lancashire Teaching Hospitals NHS Foundation Trust

Specialist Areas: Prostate, testicular and bladder tumours

Specialist Interests: Chemotherapy of urological tumours; targeted therapy; radiotherapy developments

Research Interests: Member NCRI prostate clinical study group and bladder clinical study group. Phase 2 and 3 studies of systemic therapy in urological cancers, chemoradiation and radiotherapy advances in urological tumours; survivorship

Clinics: Oncology Clinic

Languages Spoken: English

Awards and Prizes: Distinctions in MBBS in pathology, obstetrics, medicine, and clinical pharmacology; Humphrey Arthurer prize for final MB BS; Geoffrey Pegrum memorial fund travel scholarship; British Medical & Dental Students Trust Award for Elective Study; 3M Healthcare Award for Elective Essay; Best scientific paper, British Association of Urological Surgeons annual meeting (2005); Best clinical paper, British Prostate Group (2004); Royal College of Radiologists Annual Scientific meeting junior forum presentation prize (2000); Appointed Honorary Clinical Senior Lecturer University of Manchester (2007) 


Back to the list

Our consultant shortlisted for innovation award

NWC logo 2017

Dr Alison Birtle, one of our Consultant Oncologists has been shortlisted for a regional research and innovation award.

The North West Coast Research and Innovation Awards are designed to celebrate success for the excellent work being undertaken across the region in relation to clinical research and innovation.

At the event’s core is the desire to demonstrate how clinical research and innovation efforts have had an impact on patient care across the North West Coast and to showcase ideas.

Alison has been instrumental in a number of radiotherapy-specific developments that have directly impacted upon the services we offer our patients, such as an adaptive planning system for bladder cancer patients. Alison was the first clinician to use an adaptive technique where the bladder size and position is assessed each day, and the “plan of the day” is chosen for that patient. Not only does this reduce side effects for the patient but also ensures that the optimal benefit is gained from the treatment.

Jacqueline Pirmohamed, Chief Operating Officer of the National Institute for Health Research – Clinical Research Network North West Coast, said: “This event is a fantastic opportunity to celebrate the region’s achievements and success relating to research and innovation. Over 30,000 people took part in clinical research studies last year across NHS organisations on the North West Coast.

“I would like to say thank you to all of our 42 partner organisations who contributed to this, a number of whom will be commended, rewarded and celebrated as part of the NWC Research and Innovation Awards 2017. Most importantly, this event is also about the many patients and other individuals across the region who have given up their valuable time, at challenging times in their lives, to benefit our understanding of disease and its treatment. This evening will be an opportunity to showcase what a difference their contribution has made to delivery of healthcare in this region.”